Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis (RANGE)
Conditions
Interventions
FX006
Normal Saline
Locations
27
United States
Central Research Associates
Birmingham, Alabama, United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Affinity Orthopedic Specialists
Birmingham, Alabama, United States
Coastal Clinical Research, Inc.
Mobile, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Start Date
November 7, 2019
Primary Completion Date
June 15, 2020
Completion Date
June 15, 2020
Last Updated
January 24, 2024
NCT07328295
NCT07057037
NCT07203963
NCT02283996
NCT06976671
NCT06668415
Lead Sponsor
Pacira Pharmaceuticals, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions